Doughnut miss out – Update your details for a chance to win! Ensure your information is up to date and enjoy timely updates delivered straight to your inbox. Plus, you could be...

The second issue of Milton Spark* is out now and available at the Innovation Centre, Bee House, Didcot Parkway and Oxford train stations and the Milton Park buses. Launched in Spring 2025,...

Milton Park has become home to one of the UK’s most advanced green-tech manufacturing platforms, thanks to an innovation from clean-tech occupier Nium. The Earthshot Prize-nominated company is on a mission to tackle...

Image caption: ©Tokamak Energy. All Rights Reserved. A summary of recent news and announcements from Milton Park-based companies:  Physiomics appoints Head of Biometrics and signs its first biometrics contracts  Milton Park-based mathematical...

A summary of recent news and announcements from Milton Park-based companies:  Adaptimmune Therapeutics’ Tecelra to generate $35m to $45m this year Milton Park-based Adaptimmune Therapeutics has announced its treatment for solid tumour...

A summary of recent news from Milton Park including Evotec, Immunocore, Lexica, Recursion, Summit Therapeutics and Tokamak Energy. Photo © Tokamak Energy

©Oxitec. All Rights Reserved.

We are delighted to launch Milton Spark*, our new magazine dedicated to celebrating the UK’s largest single ownership innovation community for science, business and technology. Milton Park is more than just a...

Image caption: ©Oxitec Ltd. All Rights Reserved. News and announcements from Milton Park based companies: Immunocore presents data for HIV functional cure Milton Park-based Immunocore has presented initial data for a functional...

Image caption: JOURNAVX bottle and tablet (photo: Vertex Pharmaceuticals / Business Wire) From fighting cancer to tackling pain, several Milton Park occupiers have received milestone approvals from the US Food & Drug...

Biotech’s devices speed up sepsis testing from days to hours Momentum Bioscience, a biotech company pioneering rapid sepsis diagnostics, has relocated to Oxfordshire’s Milton Park, the UK’s largest single-ownership innovation community.   Established...

Three decades, one location – global consultancy strengthens Oxfordshire presence  Milton Park has revealed Tetra Tech, a global consultancy and engineering firm, has relocated one of its primary UK client hubs into...

. News and announcements from Milton Park based companies: EnSilica secures £10.38m grant for satellite broadband innovation  The UK Space Agency has granted EnSilica £10.38 million to develop advanced semiconductor chips for...

Start-up to manufacture quantum computers in Oxfordshire Image: L-R – Tom Booker (MEPC), Mandy Birch (TreQ), Anna Fletcher (MEPC) and Gibson Armstrong (TreQ) US-based quantum computing start-up TreQ is setting up shop in...

Image: ©Ensilica. All Rights Reserved.

Dosing marks a milestone for first engineered cell therapy approved in the US for a solid tumour cancer, synovial sarcoma. Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment...

Image: ©Recursion. All Rights Reserved.

Leading publishing group doubles its presence and shares Christmas bestseller prediction  The UK’s second largest book publishing group, Hachette UK, has announced a significant expansion of its Milton Park facilities in a...

Image: ©Gylden Pharma Limited. All Rights Reserved.

Life science and biotech trio announce move into Oxfordshire’s largest co-working and flexible office space Over two years on from opening Oxfordshire’s largest co-working and flexible office space, Milton Park has announced...

Image: ©Oxitec Limited. All Rights Reserved.

Image caption (L-R): Jim Al-Khalili, Veronica Reynolds, Anna Fletcher, Georgina Taylor.

Image: ©OBN (UK) Ltd. All Rights Reserved.

Image: ©Tokamak Energy Ltd. All Rights Reserved.

©Vertex Pharmaceuticals Incorporated. All Rights Reserved.

We are working hard on the exciting plans for Signal Yard, a redevelopment which will transform and reinvigorate the Park Centre. The scheme will bring forward a new amenities hub, complete with convenience...

A summary of recent news and announcements from Milton Park-based companies: Grey Wolf Therapeutics closes £39m Series B financing Grey Wolf Therapeutics, a clinical-stage biotech company based at Milton Park, has secured...

Have you seen our digital screens? If you work in a multi-occupied building, have visited the Innovation Centre for a meeting or had lunch in the Bee House, you may have seen...

A summary of recent news and announcements from Milton Park based companies: Breakthroughs in cancer treatment at Summit Therapeutics Summit Therapeutics has shown significant operational progress with ivonescimab, a novel bispecific antibody. The...

University spin-out moves HQ to commercialise disruptive technology Verdel Instruments, a start-up specialising in mass spectrometry, has relocated its headquarters from Surrey to Milton Park. Having spun-out from Warwick University in 2019,...

Biotech company NeoVac has relocated to a new fitted lab and office space at Milton Park. The move into the CL2 laboratories at 127 Olympic Avenue, will allow NeoVac to scale and...

Leading not-for-profit education technology company joins Milton Park Milton Park has welcomed Jisc, the UK’s leading digital, data and technology agency focused on higher education, research and innovation, to their recently refurbished...

From milestones in patient care, promising financial outlooks and treatment data, growth and discoveries continue to progress at Milton Park.   Isansys and XRP Healthcare partnership to improve healthcare in Africa  Park-based Isansys,...

Recent updates showcase lots of potential within the scientific community at Milton Park. From groundbreaking therapies to financial growth, occupiers have a spring in their step at the Park. Immunocore expands reach...

In this month’s Park People, the Milton Park team learns how missing out on veterinary school, two rounds of malaria and a life dodging crocodiles enabled Oxitec’s Elin Cunningham to come back...

How musicals, high fashion and kettles could unlock green hydrogen  Although a critical player in our transition towards a greener future, the production of hydrogen has a darker side. An estimated 98%...

From promising advancements in the development of fusion energy, to oncology and environmentally friendly pesticides, Milton Park’s occupiers have been busy with breakthroughs in recent months. The team looks at some of...

Recent funding announcements from Eden Research, Isansys Lifecare and Immunocore show how occupiers based at Milton Park are benefitting from an injection of investment and sustained growth. Eden Research Eden Research forecasts...

Recent advancements driven by Adaptimmune, Exscientia and Emergex Vaccines highlight developments in both cancer treatments and vaccinations, offering a glimpse into the progressive direction of ongoing clinical research taking place at Milton...